Qing Ni

Qing Ni


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
YZYang Zhang
Yang Zhang
QNQing Ni
Qing Ni
YCYuPeng Chen
YuPeng Chen
ZPZhenzhen Pei
Zhenzhen Pei
XXXinyao Xu
Xinyao Xu
Diabetes mellitus (DM) is a metabolic disorder characterized by chronic hyperglycemia, with pancreatic β-cell dysfunction and oxidative stress playing central roles in its pathogenesis. Recent studies have identified disulfidptosis as a novel form of regulated cell death driven by disulfide stress,a condition marked by abnormal intracellular disulfide accumulation and NADPH/NADP+ imbalance. This process is particularly prominent in glucose-deprived cells with high expression of the cystine transporter SLC7A11, where impaired disulfide reduction leads to cytoskeletal collapse and cell death. Disulfide stress arises from multiple sources, including persistent protein glutathionylation, aberrant disulfide bond formation in cysteine-rich proteins, and irreversible oxidation of thiol groups. Beyond triggering disulfidptosis, disulfide stress exacerbates oxidative damage and inflammatory responses through complex signaling cascades, contributing to DM progression. This review systematically examines the molecular mechanisms of disulfidptosis, highlighting its interplay with redox systems such as thioredoxin (Trx) and glutaredoxin (Grx). We further explore how disulfide stress influences the pathophysiology of DM complications, including diabetic nephropathy, cardiomyopathy, vascular dysfunction, and retinopathy, with emphasis on the dual roles of the Trx-interacting protein (TXNIP) in these processes. Finally, we discuss emerging therapeutic strategies targeting disulfide stress, such as TXNIP inhibition and redox system modulation, to preserve β-cell function and mitigate end-organ damage. By integrating current evidence this review provides a framework for developing targeted interventions to improve DM management in the coming years.

24 April 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
YTYiting Tang
Yiting Tang
YCYupeng Chen
Yupeng Chen
YZYang Zhou
Yang Zhou
BWBingrong Wu
Bingrong Wu
SZShan Zhang
Shan Zhang
QNQing Ni
Qing Ni
Background: Type 2 Diabetes Mellitus (T2DM) poses a significant global health challenge, particularly among elderly adults. Dietary risk factors, such as high consumption of processed meats and sugar-sweetened beverages and low intake of whole grains and fruits, play a critical role in the burden of T2DM. This study aims to comprehensively quantify the global burden of T2DM attributable to dietary risks among elderly adults, identify significant dietary risk factors driving disease burden, and evaluate temporal, regional, and demographic variations to inform targeted public health strategies and interventions for reducing the impact of T2DM.Methods: This study utilized data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 to assess T2DM burden attributable to dietary risks among adults aged 65 years and older across 204 countries and territories. Metrics included age-standardized mortality rates (ASMR) and disability-adjusted life-year rates (ASDR). Dietary risk factors analyzed included low intake of whole grains, fruits, vegetables, and fiber, as well as high intake of processed meat, red meat, and sugar-sweetened beverages. Joinpoint regression and decomposition analyses were performed to examine temporal trends and drivers of changes by region, SDI level, sex, and age.Results: In 2021, dietary risks accounted for 23.61% of T2DM-related deaths and 24.85% of DALYs among elderly adults. ASMR showed a slight decline globally (AAPC: −0.08), while ASDR exhibited a significant upward trend (AAPC: +0.7) from 1990 to 2021. High SDI regions demonstrated decreasing ASMR but persistent DALYs due to prolonged survival with complications. Conversely, low and middle SDI regions exhibited rapid increases in ASMR and ASDR, driven by dietary transitions and limited healthcare resources. Males consistently bore a higher burden than females, with pronounced disparities in low and middle SDI regions. Aging and population growth were the primary drivers of the increasing burden globally.Conclusion: This study underscores the substantial burden of T2DM attributable to dietary risks among elderly adults and highlights significant regional and demographic disparities. Targeted public health interventions, personalized nutritional strategies, and improved healthcare access are essential to mitigate this burden. Future research should explore the impact of emerging dietary trends and precision nutrition on T2DM prevention and management.

15 June 2026 in World Journal of Diabetes
Verified
Journal Article
Closed access
YTYi-Ting Tang
Yi-Ting Tang
YCYu-Peng Chen
Yu-Peng Chen
YYYa-Nan Yang
Ya-Nan Yang
JLJun-Li Liu
Jun-Li Liu
QWQian Wu
Qian Wu
QNQing Ni
Qing Ni
BACKGROUND Shenqi Jiangtang Granules (SQJT), a traditional Chinese patent medicine, have long been prescribed for type II diabetes mellitus. Increasing evidence suggests that SQJT has cardioprotective effects; however, its mechanisms in diabetic cardiomyopathy (DCM), particularly regarding ferroptosis, remain unclear. We hypothesized that SQJT protects against DCM by inhibiting ferroptosis via the dihydroorotate dehydrogenase (DHODH)/coenzyme Q (CoQ) signaling pathway. AIM To elucidate the mechanism through which SQJT attenuates ferroptosis in DCM. METHODS Active constituents of SQJT were obtained from previous mass spectrometry analyses. Potential targets were predicted using network pharmacology, protein-protein interaction, molecular docking, and dynamics simulation. Cell viability, death, and ferroptosis markers were assessed in high glucose/lipid-induced H9C2 cells. Intracellular iron, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), glutathione (GSH), and reactive oxygen species (ROS) levels were measured, and mitochondrial morphology was examined by MitoTracker staining. The expression of DHODH/CoQ pathway components was analyzed by reverse transcription-quantitative PCR and Western blotting, and pathway dependence was confirmed using the DHODH inhibitor brequinar (BRQ). RESULTS The SQJT-DCM-ferroptosis network identified 16 intersecting targets, with DHODH as the primary candidate. SQJT significantly improved cell viability and attenuated ferroptosis. Specifically, treatment with 6% SQJT reduced intracellular free iron levels by 61.8% and lipid peroxidation (MDA) levels by 55.9% (all P < 0.001). Furthermore, SQJT restored antioxidant enzyme activities (SOD and GSH-PX) by over 100%, while maintaining mitochondrial membrane integrity and reducing the proportion of ROS-positive cells from 51.6% to 11.8%. These protective effects, mediated via the DHODH/CoQ signaling axis, were significantly abolished by BRQ. CONCLUSION SQJT alleviates ferroptosis and oxidative stress, potentially through modulation of the DHODH/CoQ pathway, while preserving mitochondrial integrity and enhancing cardiomyocyte survival, suggesting its therapeutic potential in DCM. However, the mechanistic findings were based on pharmacological inhibition rather than genetic validation. Therefore, further genetic and in vivo studies are needed.